Leuprolide Completed Phase 4 Trials for Central Precocious Puberty (CPP) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02920515Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty
NCT01634321The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty